UNSPSC 51453402: Niridazole

This classification denotes an antiprotozoal agent with the molecular formula C6H6N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N116U8Y5QQ, chemically known as 2-imidazolidinone, 1-(5-nitro-2-thiazolyl)- but generally known as niridazole, which bears US NIH Compound Identifier 6093. European Medicines Agency schedules Niridazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09304MIG.

UNSPSC 51453402 Niridazole, a Commodity code, shows minimal alignment between its nominal scope and recent state and local solicitation activity. The code nominally describes a specific pharmaceutical compound (niridazole, an antiparasitic agent), yet recent opportunities tagged under this code predominantly solicit naloxone, medical and first aid supplies, generic pharmaceuticals, and direct-to-manufacturer prescription programs — product categories that diverge substantially from niridazole's clinical use and market positioning. State and local buyers using this code include county health departments, city fire departments, state health and human services agencies, and multistate cooperative purchasing alliances. The issuing bodies range from specialized health procurement (Seminole County Community Health) to municipal emergency services (City of Tampa Fire Department) and statewide cooperative vehicles (Minnesota Multistate Cooperative Purchasing Alliance, Texas Health and Human Services Commission).

Recent activity spans Florida, Texas, and Minnesota. The Seminole County, Florida IFB (IFB60459723LAS, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives. The City of Tampa's ITB (26P00145, due March 13, 2026) solicited 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000 and a small local business enterprise set-aside offering a 5 percent discount. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities. The Texas Health and Human Services Commission posted an RFI (HHS0017013, due April 3, 2026) exploring direct-to-manufacturer prescription programs. The code shows no recent activity genuinely aligned with niridazole procurement; tagging misalignment suggests the UNSPSC classification may not accurately reflect current procurement practice under this code number.